The Pentavalent Rotavirus Vaccine: Discovery to Licensure and Beyond
Open Access
- 15 December 2007
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 45 (12), 1618-1624
- https://doi.org/10.1086/522997
Abstract
Twenty-five years passed between the discovery of the parent strain (WC3) of the pentavalent human-bovine reassortant rotavirus vaccine (PRV) in 1981Keywords
This publication has 22 references indexed in Scilit:
- Safety and Efficacy of a Pentavalent Human–Bovine (WC3) Reassortant Rotavirus VaccineNew England Journal of Medicine, 2006
- Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccineReviews in Medical Virology, 2004
- Global Illness and Deaths Caused by Rotavirus Disease in ChildrenEmerging Infectious Diseases, 2003
- Intussusception among Infants Given an Oral Rotavirus VaccineNew England Journal of Medicine, 2001
- Efficacy and safety of high-dose rhesus-human reassortant rotavirus vaccine in Native American populationsThe Journal of Pediatrics, 1997
- Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritisThe Lancet, 1997
- Rotavirus Infection in Infants as Protection against Subsequent InfectionsNew England Journal of Medicine, 1996
- The Development Of Multivalent Bovine Rotavirus (Strain Wc3) ReassortantThe Journal of Infectious Diseases, 1996
- Rotaviruses: Immunological Determinants of Protection Against Infection and DiseasePublished by Elsevier ,1994
- Clinical features of acute gastroenteritis associated with human reovirus-like agent in infants and young childrenThe Journal of Pediatrics, 1977